Literature DB >> 726570

[Experiences with Refobacin-Palacos with regard to deep late infections following hip-joint endoprosthesis surgery. A 4-years' study (author's transl)].

L Thierse.   

Abstract

667 TEP operations were performed in our hospital from 1970 to 1973. Two groups of patients were treated either with Palacos-R without addition of antibiotics (n = 336) or with Refobacin-Palacos (n = 331). Both groups received a combined postoperative systemic antibiotic infection prophylaxis. The authors' own subsequent investigations, completion of patient questionnaires and--in case of subjective complaints--medical questionnaires, were sufficient to follow up all patients, with the exception of two, over a period of 5--4 or 4--3 years. The infection rate in the group without addition of antibiotics was 6,3 or 4,1% for early or late infections respectively, in the Palacos group, whereas in the Refobacin-Palacos group the rate of early or late infections was only 0,6%. No sensitization in respect of the incorporated gentamycin antibiotic was found.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 726570

Source DB:  PubMed          Journal:  Z Orthop Ihre Grenzgeb        ISSN: 0044-3220


  3 in total

1.  In vitro testing of antimicrobial activity of bone cement.

Authors:  Volker Alt; Thorsten Bechert; Peter Steinrücke; Michael Wagener; Peter Seidel; Elvira Dingeldein; Eugen Domann; Reinhard Schnettler
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

2.  [Nanoparticulate silver. A new antimicrobial substance for bone cement].

Authors:  V Alt; T Bechert; P Steinrücke; M Wagener; P Seidel; E Dingeldein; D Scheddin; E Domann; R Schnettler
Journal:  Orthopade       Date:  2004-08       Impact factor: 1.087

3.  Antimicrobial rationing in orthopaedic surgery.

Authors:  Shao-Ting Jerry Tsang; A Hamish R W Simpson
Journal:  Bone Joint Res       Date:  2020-12       Impact factor: 4.410

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.